This webinar will be eligible for Certified Health Education Specialist (CHES) credits in health education. One (1) CECH has been approved for advanced-level credit.
*NEW* This webinar is eligible for 1.5 CME credits through Meharry Medical College. If you are interested in receiving CME credits for participation in this webinar, please download and complete the CME evaluation form. The completed CME evaluation form must be emailed to minorityHealth@hhs.gov, by no later than Thursday, October 24, 2019. After completed evaluation forms are received by Meharry Medical College, a CME certificate will be emailed to you.
A copy of the CME evaluation form can be found here: https://www.minorityhealth.hhs.gov/assets/pdf/CME_EVALUATION_FORM2_OMH_Webinar.pdf
This webinar will highlight the use of FDA-approved medications in combination with counseling and behavioral therapies, collectively known as medication-assisted treatment (MAT), for the treatment of opioid use disorder among people of color. Speakers will discuss the utilization of MAT among providers, treatment challenges, and strategies for providing MAT in health care settings that treat racial and ethnic minority populations.
Objectives:
- Provide an overview of the epidemiology of the opioid epidemic, including differences by race/ethnicity
- Explain opioid use disorder treatment options and benefits, including differences by race/ethnicity, and naloxone utilization for opioid overdose prevention
- Address concerns about and challenges in providing MAT
- Describe strategies for providing MAT in health care settings that treat racial and ethnic minority populations, including an integrated care model, the use of telehealth, and addressing the social determinants of health through community partnerships
- Identify and share resources for providers and other stakeholders to facilitate the implementation of culturally and linguistically appropriate treatment strategies
Speakers:
Chinazo O. Cunningham, M.D., M.S., Associate Chief, Division of General Internal Medicine, Director of Research Resources, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine
Tiffany Lu, M.D., Medical Director, Montefiore Buprenorphine Treatment Network, Montefiore Medical Center/Albert Einstein College of Medicine
Edwin C. Chapman, M.D., DABIM, FASAM, Chief Medical Officer, Medical Home Development Group
Wanda Brown, Peer Recovery Coach, Medical Home Development Group
Moderator:
Juliet Bui, MPA, MSW, Public Health Analyst, Office of Minority Health, U.S. Department of Health and Human Services